New York – December 6, 2022 – Medidata, a Dassault Systèmes company, launched a new patient-centric native myMedidata app, designed to provide trial participants with another option for a seamless platform experience and a single login for all their remote trial activities. The app will feature all of the myMedidata patient-centric solutions, with an initial focus on eCOA (electronic clinical outcome assessments). The myMedidata app is available on iOS and Android and can be used both on the patients’ own devices (BYOD) or via a provisioned device.
“Our latest addition to myMedidata brings an innovative app to patients designed in concert with our patient insights team, customer feedback, and the experiences derived from running the world’s biggest DCTs over the last twenty years,” said Matt Noble, senior vice president, Medidata Patient Cloud. “Medidata is leveraging its unique insights from sponsors, CROs, sites, and patients to make a meaningful difference in the clinical trial experience.”
Unique to the industry, the myMedidata app is unified with the Medidata Platform, including Rave EDC (electronic data capture), resulting in an entirely self-sustaining ecosystem where patient input, site based activities, and behind the scenes data management seamlessly operate together.
The app is configured using Medidata Designer, a new platform configuration tool, bringing a patient-centered mobile-first workflow builder to the myMedidata app. With Designer, sponsors and CRO partners can build a rich patient experience via intuitive drag and drop screen templates and visual workflow tools, which simultaneously in the background set up a clinical database without the need for any custom code. Designer drastically lowers study build times by employing Medidata and client libraries, including pre-built eCOA instruments, translations, and study configurations.
Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 32,000 trials and 9 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,100+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit https://www.3ds.com